Zobrazeno 1 - 10
of 30
pro vyhledávání: '"E. Zheleznova"'
Autor:
A N Rogoza, Marina V. Kostiukevich, Panchenko Ep, Iuliia A. Iuricheva, Alexander Litvin, E. Zheleznova, I E Chazova, E M Elfimova, Madina D. Utsumueva, Sergei P. Golitsyn, Lada Iu. Laiovich, Juliya V. Zhernakova, Kropacheva Es, Nikolai Iu. Mironov
Publikováno v:
Системные гипертензии, Vol 18, Iss 3, Pp 105-128 (2021)
Arterial hypertension (AH) is a leading risk factor for cardiovascular disease as well as it is the most common, independent and potentially reversible risk factor for atrial fibrillation (AF). AH contributes to the occurrence and maintenance of AF d
Autor:
N V Blinova, E. Zheleznova, Juliya V. Zhernakova, Irina Е. Chazova, M. Saidova, Sergei K. Ternovoy, M. Azimova, Makka Azimova
Publikováno v:
Системные гипертензии, Vol 17, Iss 4, Pp 74-79 (2021)
The negative role of epicardial adipose tissue (EAT) in the development of cardiovascular diseases makes it possible to use it as a new marker for assessing and predicting cardiovascular risk in obese individuals. Computed tomography (CT) remains the
Autor:
Juliya V. Zhernakova, A N Rogoza, E. Zheleznova, M. Saidova, Marina V. Andreevskaia, Irina Chazova, Merab A. Shariia, A. Zairova, M. Azimova, N V Blinova
Publikováno v:
Системные гипертензии, Vol 17, Iss 4, Pp 55-62 (2021)
Overweight is closely associated with development of cardiovascular disorders. Currently, the terms metabolically healthy abdominal obesity (MHAO) and metabolically unhealthy obesity, i.e., metabolic syndrome (MS) are stated. Comparison target organs
Autor:
M. Azimova, E. Zheleznova, Juliya V. Zhernakova, Tatiana V. Sharf, Valerii P. Masenko, N V Blinova, I E Chazova, Merab A. Shariia
Publikováno v:
Consilium Medicum. 22:23-30
Fibroblast Growth Factor 21 (FGF21) is a hormone-like protein involved in the regulation of energy balance and glucose and lipid homeostasis. The study of the association of this factor with the metabolic phenotype – metabolically healthy (MHAO) an
Autor:
Tatiana V Balakhonova, Shurat B Gorieva, Andrei V Maslov, O A Pogorelova, N V Blinova, M. Azimova, Juliya V. Zhernakova, I E Chazova, Mariia I Tripoten, E. Zheleznova, M.A. Shariya
Publikováno v:
Системные гипертензии, Vol 16, Iss 4, Pp 80-86 (2019)
Aim. To evaluate the common carotid artery (CCA) intima-media complex thickness (IMT) and the presence of atherosclerotic plaques (ASP) in young people with abdominal obesity who don’t have metabolic syndrome and those who have it, as well as a lin
Autor:
A N Rogoza, I E Chazova, E. Zheleznova, A A Orlovsky, M. Azimova, Elena Yarovaya, I D Konosova, N V Blinova, M.A. Shariya, A. Zairova, Yu V Zhernakova, S. Gorieva
Publikováno v:
Системные гипертензии, Vol 15, Iss 4, Pp 76-82 (2018)
Obesity plays a key role in the epidemic of type 2 diabetes mellitus (DM), cardiovascular and cerebrovascular diseases. Most studies confirm the association of increased arterial stiffness with obesity. However, the interrelation of various fat depot
Autor:
O. P. Rotar, S. A. Shalnova, A.O. Konradi, I D Konosova, Elena V. Oshchepkova, Elena Yarovaya, Evgeny Shlyakhto, E. Zheleznova, A A Orlovsky, N V Blinova, Yu V Zhernakova, Sergey Boytsov, I E Chazova, Yu A Dolgusheva
Publikováno v:
Терапевтический архив, Vol 90, Iss 10, Pp 14-22 (2018)
Abdominal obesity (AO) is a predictor of cardiovascular disease and diabetes mellitus type 2. The assessment of the disease prevalence and the study of socioeconomic status of people with this phenotype of obesity are necessary to develop effective m
Publikováno v:
Journal of Hypertension. 39:e152
Autor:
Vera Shamshilina, E. Zheleznova, Sergey Ternovoy, Y. Zhernakova, Makka Azimova, M. Saidova, N. Blinova, M. Azimova, Irina Chazova
Publikováno v:
Journal of Hypertension. 39:e335
Autor:
T.V. Balakhonova, S. Gorieva, O A Pogorelova, E. Zheleznova, M. Tripoten, A. Maslov, M. Azimova, M.A. Shariya, Yu V Zhernakova, N V Blinova, Irina Е. Chazova
Publikováno v:
Journal of Hypertension. 39:e330